Page last updated: 2024-09-05

elarofiban and Disease Models, Animal

elarofiban has been researched along with Disease Models, Animal in 1 studies

*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andrade-Gordon, P; Corcoran, T; Damiano, BP; de Garavilla, L; Giardino, E; Haertlein, BJ; Hoekstra, WJ; Kauffman, JA; Maryanoff, BE; Mitchell, JA	1

Other Studies

1 other study(ies) available for elarofiban and Disease Models, Animal

Article	Year
Antiplatelet and antithrombotic activity of RWJ-53308, a novel orally active glycoprotein IIb/IIIa antagonist. Thrombosis research, 2001, Oct-15, Volume: 104, Issue:2 Topics: Animals; Biological Availability; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fibrinogen; Guinea Pigs; Humans; Inhibitory Concentration 50; Nipecotic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Pyridines; Rats; Thrombosis	2001

Article

Year

Antiplatelet and antithrombotic activity of RWJ-53308, a novel orally active glycoprotein IIb/IIIa antagonist.

Thrombosis research, 2001, Oct-15, Volume: 104, Issue:2

Topics: Animals; Biological Availability; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fibrinogen; Guinea Pigs; Humans; Inhibitory Concentration 50; Nipecotic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Pyridines; Rats; Thrombosis

2001